Women's Hormones 101

Build practical foundations in the hormone health of women
In aesthetic medicine, we frequently manage the visible effects associated with hormonal changes and ageing, specifically the loss of dermal collagen, reduced skin elasticity and shifts in adipose distribution. While topical and injectable interventions are effective, treatment outcomes are influenced by the patient's underlying physiological environment, including hormonal status.

To provide truly comprehensive care, it is essential to understand how hormones dictate the skin’s response to treatment.
We have partnered with Newson Education to host their specialist hormone training on DermaHub. Led by Dr Louise Newson and Dr Rebecca Lewis, experienced clinicians and educators in hormone health, this 7-CPD-point module goes beyond surface-level aesthetics, equipping you with the knowledge to recognise hormone related patterns, communicate effectively with patients and refer appropriately where needed. 
CPD

7 Points

Videos

Duration

7 Hours

Build practical foundations in the hormone health of women

Women’s Hormones 101 provides a clear clinical foundation in hormone signalling and the roles of estradiol, progesterone and testosterone across the reproductive lifespan. It moves beyond “stages” to help you recognise hormone-related presentations as multi-system patterns, and apply more confident decision-making around assessment and treatment – including HRT.

 You’ll learn how to assess presentations more confidently, choose appropriate investigations, and make clearer decisions around hormone treatment options, monitoring and follow-up – expanding your practice, supporting safer care and better patient outcomes.

Women’s Hormones 101 has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Apex Longevity Academy and Newson Education. Apex Longevity Academy is accredited by the ACCME to provide continuing medical education for physicians.

Key outcomes from Women's Hormones 101

  • Understand hormone signalling and why hormone-related symptoms are often misattributed
  • Build a working knowledge of estradiol, progesterone and testosterone beyond reproduction (brain, bone, cardiovascular, immune)
  • Recognise how hormonal fluctuation presents across the lifespan (cycle, pregnancy/postnatal, perimenopause, menopause)
  • Make clearer decisions about when to consider hormone treatment (including HRT), and when to investigate or refer
  • Choose between hormone formulations and routes based on symptoms, history, preferences and tolerability
  • Hold clearer benefit–risk conversations using shared decision-making

How this module improves your clinical practice

Hormone-related presentations often show up as broad, non-specific symptom clusters – mood and sleep disruption, cognitive changes, palpitations, joint pain, fatigue, weight change and menstrual changes – making them easy to misattribute without a clear physiological framework.

Women’s Hormones 101 strengthens day-to-day clinical practice by providing the foundations to recognise hormone-related patterns earlier, use investigations more appropriately and make safer decisions around hormone treatment, monitoring and follow-up. By integrating this understanding of hormone health into your consultations, you can enhance patient assessment, support more realistic treatment planning, strengthen clinical decision-making and improve risk awareness with appropriate signposting.

Who this module is good for

  • GPs and primary care clinicians managing high volumes of women’s health and multi-system presentations
  • Prescribing pharmacists supporting investigation, optimisation and safe monitoring
  • Nurses with independent prescribing responsibilities
  • Clinicians working in women’s health, lifestyle or longevity medicine who want a more structured approach to hormone-related care
  • Clinicians who don’t prescribe but support patient assessment, interpretation, counselling and follow-up within a prescribing pathway

Course Content

Inclusive Language Statement

Throughout, our courses we refer to perimenopause, menopause and other hormone-related conditions (for example premenstrual syndrome and premenstrual dysphoric disorder) that commonly affect women. In this context, the terms “women”, “woman” and “female” are used inclusively to describe anyone who experiences these hormonal changes, including people who may identify as transgender, gender-fluid, agender or non-binary. We also refer to andropause and other hormone-related conditions that commonly affect men, the terms “men”, “man” and “male” are used inclusively to describe anyone who experiences these hormonal changes, including people who may identify as transgender, gender-fluid, agender or non-binary.